GRI Bio, Inc. (GRI)
2.33
+0.08
(+3.56%)
USD |
NASDAQ |
Feb 13, 16:00
2.29
-0.04
(-1.72%)
After-Hours: 20:00
GRI Bio Total Liabilities (Quarterly) : 2.658M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 11.57M |
| Ekso Bionics Holdings, Inc. | 11.98M |
| Akari Therapeutics Plc | 22.69M |
| Moleculin Biotech, Inc. | 47.27M |
| Autonomix Medical, Inc. | 1.65M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.666M |
| Shareholders Equity (Quarterly) | 6.008M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 3.251 |
| Net Debt Paydown Yield | 0.35% |